DanDrit Overview
- Founded
-
2001

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
DanDrit General Information
Description
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing gene therapies. It develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccine and cures and Cellular immune-oncology products.
Contact Information
Website
www.dandrit.com
Formerly Known As
DanDrit Biotech USA
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Enochian BioSciences
Primary Office
- 375 Park Avenue
- Suite 2607
- New York, NY 10152
- United States
DanDrit Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
DanDrit Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing and com
Drug Discovery
New York, NY
000.00
000000&0
000.00
DanDrit Competitors (33)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Northwest Biotherapeutics | Corporation | Bethesda, MD | 00 | 00000 | 000000000 - | 00000 |
0000000000 | Corporate Backed or Acquired | Baton Rouge, LA | 000000000000 | |||
00000 000000000000 | Formerly VC-backed | Watertown, MA | 000 | 00.000 | 00000000 | 00.000 |
000 000000000000 | Formerly VC-backed | Epalinges, Switzerland | 000 | 00.000 | 00000000 | 00.000 |
0000000 0000000000 | Venture Capital-Backed | Cambridge, United Kingdom | 00 | 00000 | 00000000000 | 00000 |
DanDrit Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Luisa Puche | Chief Financial Officer & Principal Accounting Officer |